Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Jun 2026, Jul 2026 and Aug 2026.
- Largest single sale: $282K (3,801 shares) of Dexcom on Jun 15, 2026. Filing
- Last sale before this period: Aug 15, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Dexcom (DXCM) | Director | Nov 19, 2014 | Aug 4, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 3, 2026, Dexcom: sold 2,000 shares for $171K, under a disclosed plan (some held indirectly). 1 filing: 1
- Jul 31, 2026, Dexcom: sold 2,000 shares for $160K, under a disclosed plan (some held indirectly). 1 filing: 1
- Jun 15, 2026, Dexcom: sold 4,000 shares for $297K, under a disclosed plan (some held indirectly). 1 filing: 1
- May 28, 2026, Dexcom: 6,331 shares granted. 1 filing: 1
- May 8, 2026, Dexcom: 11,462 shares moved between their own holdings (some held indirectly). 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.